课题基金 / 基金详情

IMMUNOTHERAPY OF MALIGNACY BY IN VIVO GENE TRANSFER INTO TUMORS

IMMUNOTHERAPY OF MALIGNACY BY IN VIVO GENE TRANSFER INTO TUMORS
通过体内基因转移至肿瘤来免疫治疗恶性肿瘤
批准号：
6113382
负责人：
ALFRED E CHANG
金额：
$0.02万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6113382
关键词：
DNA clinical research clinical trial phase I gene therapy histocompatibility antigens human subject human therapy evaluation liposomes major histocompatibility complex neoplasm /cancer immunotherapy transfection /expression vector

项目摘要

项目成果

ALFRED E CHANG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Patients with advanced cancer will be treated by delivery of a DNA/liposome complex into the tumor through catheter delivery or direct injection. DNA encoding an HLA-B7 histocompatibility antigen and the gene for beta-2 microglobulin in a eukaryotic expression vector will be used. This is a phase I trial designed to assess safety of this gene therapy approach.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IMMUNOLOGICAL MONITORING
RESEARCH TRAINING IN TRANSLATIONAL TUMOR IMMUNOLOGY
IMMUNE RESPONSES INDUCED BY GENE TRANSFER
IMMUNE RESPONSES INDUCED BY GENE TRANSFER
海外基金